SBH
SBC

Segall Bryant & Hamill’s SBC Medical Group SBC Stock Holding History

Segall Bryant & Hamill’s Portfolio SBC Stock Details SBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$340K Buy
+81,307
New +$339K ﹤0.01% 568

Other funds holding SBC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Segall Bryant & Hamill's SBC Position: Q1 2026 in Review

Segall Bryant & Hamill opened a new position in SBC Medical Group (SBC) in Q1 2026: 81,307 shares worth $340K. The stake represents ﹤0.01% of the portfolio and ranks #568 among its holdings.

50 funds tracked by Wall St. Rank hold SBC as of Q1 2026.

  • Segall Bryant & Hamill held 81,307 shares of SBC Medical Group worth $340K as of Q1 2026.
  • SBC Medical Group was a new Segall Bryant & Hamill position in Q1 2026.
  • SBC Medical Group made up ﹤0.01% of Segall Bryant & Hamill's portfolio in Q1 2026, its #568 holding.
  • 50 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2026.

Based on Segall Bryant & Hamill's 13F filing for Q1 2026, filed 15 May 2026.